alexa
Reach Us +44-176-4910199
Zinc Transporters: New Insights For Cancer Therapy | 3528
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Zinc transporters: New insights for cancer therapy

2nd International Conference on Gastroenterology & Urology

Min Li

AcceptedAbstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X.S1.019

Abstract
Pancreatic cancer is the number one cancer killer with 5-year survival less than 5%. It is urgently needed to identify novel molecular markers and therapeutic targets in pancreatic cancer that could lead to more effective treatment for this deadly disease. Our recent study suggests that a dietary zinc transporter, ZIP4, is over expressed in pancreatic cancer and brain tumor, and promotes cancer growth and metastasis. Those results indicate that ZIP4 and zinc transport pathway is a novel therapeutic target for cancers. Our results also suggest that ZIP4 can serve as a cancer master switch gene to impact the downstream signaling pathways including cytokines, microRNAs, and transcriptional factors.
Biography
Min Li got his Ph.D. from Emory University in 2002. He then moved on to Baylor College of Medicine and started his career in cancer research as an Assistant Professor in 2004. He joined the University of Texas Health Science Center at Houston, Medical School in 2010 as the Director of Cancer Research Program. His research interests include pancreatic cancer and brain tumor. Dr. Li's group is the first one to identify ZIP4 as a novel molecular target in pancreatic cancer. He has published more than 100 papers and serves as an editorial board member of many peer reviewed journals.
Top